Americas Hematology Diagnostics Market

Americas Hematology Diagnostics Market Analysis By Kit (Hematology Anemia and Iron Test Kits, Folic Acid Testing Kits, Sickle Cell Screening Kits, PT/INR Testing Kits, Blood Typing Kits), By Modality (Point of Care, Lab-based testing), By Distribution Channel, By Region - Global Insights to 2031

Analysis of Americas Hematology Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Request FREE Sample

Table of Content

1. Executive Summary

    1.1. Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion & Exclusion

3. Key Market Trends

    3.1. Key Trends Impacting the Hematology Diagnostics Market

    3.2. Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. GDP Growth Outlook

        4.1.2. Healthcare Industry Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Increasing Prevalence of Chronic Diseases

        4.2.2. Diagnostic Rate (%)

        4.2.3. Increasing Self-Testing among Geriatric Population 

        4.2.4. Cost Per Test

        4.2.5. Brand Promotional Activities

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. Market Context

    5.1. Recent developments in Product Launches and approvals

    5.2. Technology Assessment

    5.3. Key Marketing Strategies, by Manufacturers

    5.4. Regulatory Scenario

6. COVID19 Crisis Analysis

    6.1. Current COVID19 and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue by Test

        6.4.2. Revenue by Country

    6.5. 2020 Market Scenario

    6.6. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Americas Hematology Diagnostics Market Value Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Americas Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Kit Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis by Kit Type, 2016-2020

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Kit Type, 2021-2031

        8.3.1.  Anaemia and Iron Test kits

        8.3.2. Folic Acid Testing Kits 

        8.3.3. Sickle Cell Screening Kits

        8.3.4. PT/INR Testing Kits 

        8.3.5. D-dimer Testing kits 

        8.3.6. Blood Typing Kits 

        8.3.7. Leukaemia Testing Kits 

        8.3.8. Sepsis Testing Kits 

        8.3.9.  Antibiotic Resistance Panels 

        8.3.10. Bacterial & Fungal Panels

    8.4. Market Attractiveness Analysis by Kit Type

9. Americas Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Modality

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis by Modality, 2016-2020

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Modality, 2021-2031

        9.3.1.  Point of Care

        9.3.2. Lab based testing

    9.4. Market Attractiveness Analysis by Modality

10. Americas Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2021-2031

        10.3.1.  Hospitals

        10.3.2. Diagnostic Laboratories 

        10.3.3. Cancer Research Institutes 

        10.3.4. Retail Pharmacies 

        10.3.5. Drug Store 

        10.3.6. Online Sales Channels

    10.4. Market Attractiveness Analysis by Distribution Channel

11. Americas Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020

    11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031

        11.3.1. North America

        11.3.2. Latin America

    11.4. Market Attractiveness Analysis By Region

12. North America Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        12.3.1.  By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Kit Type

        12.3.3. By Modality

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        13.3.1.  By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Kit Type

        13.3.3. By Modality

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. U.S. Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        14.3.1. By Kit Type

        14.3.2. By Modality

        14.3.3. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Canada Hematology Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

    15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

        15.3.1. By Kit Type

        15.3.2. By Modality

        15.3.3. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Deep Dive 

        17.2.1. BioMedomics, Inc.

            17.2.1.1. Overview

            17.2.1.2. Product Portfolio

            17.2.1.3. Analyst Commentary 

            17.2.1.4. Key Financials

            17.2.1.5. Recent Developments

            17.2.1.6. Sales Footprint

            17.2.1.7. Strategy Overview

                17.2.1.7.1. Marketing Strategy

                17.2.1.7.2. Product Strategy

                17.2.1.7.3. Channel Strategy

        17.2.2. Biomerieux SA

            17.2.2.1. Overview

            17.2.2.2. Product Portfolio

            17.2.2.3. Analyst Commentary 

            17.2.2.4. Key Financials

            17.2.2.5. Recent Developments

            17.2.2.6. Sales Footprint

            17.2.2.7. Strategy Overview

                17.2.2.7.1. Marketing Strategy

                17.2.2.7.2. Product Strategy

                17.2.2.7.3. Channel Strategy

        17.2.3. Abbott Laboratories

            17.2.3.1. Overview

            17.2.3.2. Product Portfolio

            17.2.3.3. Analyst Commentary 

            17.2.3.4. Key Financials

            17.2.3.5. Recent Developments

            17.2.3.6. Sales Footprint

            17.2.3.7. Strategy Overview

                17.2.3.7.1. Marketing Strategy

                17.2.3.7.2. Product Strategy

                17.2.3.7.3. Channel Strategy

        17.2.4. BTNX Inc.

            17.2.4.1. Overview

            17.2.4.2. Product Portfolio

            17.2.4.3. Analyst Commentary 

            17.2.4.4. Key Financials

            17.2.4.5. Recent Developments

            17.2.4.6. Sales Footprint

            17.2.4.7. Strategy Overview

                17.2.4.7.1. Marketing Strategy

                17.2.4.7.2. Product Strategy

                17.2.4.7.3. Channel Strategy

        17.2.5. i-SENS, Inc. (Coagusense Inc.)

            17.2.5.1. Overview

            17.2.5.2. Product Portfolio

            17.2.5.3. Analyst Commentary 

            17.2.5.4. Key Financials

            17.2.5.5. Recent Developments

            17.2.5.6. Sales Footprint

            17.2.5.7. Strategy Overview

                17.2.5.7.1. Marketing Strategy

                17.2.5.7.2. Product Strategy

                17.2.5.7.3. Channel Strategy

        17.2.6. Danaher (Beckman coulter)

            17.2.6.1. Overview

            17.2.6.2. Product Portfolio

            17.2.6.3. Analyst Commentary 

            17.2.6.4. Key Financials

            17.2.6.5. Recent Developments

            17.2.6.6. Sales Footprint

            17.2.6.7. Strategy Overview

                17.2.6.7.1. Marketing Strategy

                17.2.6.7.2. Product Strategy

                17.2.6.7.3. Channel Strategy

        17.2.7. Danaher (Cepheid)

            17.2.7.1. Overview

            17.2.7.2. Product Portfolio

            17.2.7.3. Analyst Commentary 

            17.2.7.4. Key Financials

            17.2.7.5. Recent Developments

            17.2.7.6. Sales Footprint

            17.2.7.7. Strategy Overview

                17.2.7.7.1. Marketing Strategy

                17.2.7.7.2. Product Strategy

                17.2.7.7.3. Channel Strategy

        17.2.8. ELDON BIOLOGICALS A/S

            17.2.8.1. Overview

            17.2.8.2. Product Portfolio

            17.2.8.3. Analyst Commentary 

            17.2.8.4. Key Financials

            17.2.8.5. Recent Developments

            17.2.8.6. Sales Footprint

            17.2.8.7. Strategy Overview

                17.2.8.7.1. Marketing Strategy

                17.2.8.7.2. Product Strategy

                17.2.8.7.3. Channel Strategy

        17.2.9. F. Hoffmann-La Roche Ltd

            17.2.9.1. Overview

            17.2.9.2. Product Portfolio

            17.2.9.3. Analyst Commentary 

            17.2.9.4. Key Financials

            17.2.9.5. Recent Developments

            17.2.9.6. Sales Footprint

            17.2.9.7. Strategy Overview

                17.2.9.7.1. Marketing Strategy

                17.2.9.7.2. Product Strategy

                17.2.9.7.3. Channel Strategy

        17.2.10. Grifols, S.A

            17.2.10.1. Overview

            17.2.10.2. Product Portfolio

            17.2.10.3. Analyst Commentary 

            17.2.10.4. Key Financials

            17.2.10.5. Recent Developments

            17.2.10.6. Sales Footprint

            17.2.10.7. Strategy Overview

                17.2.10.7.1. Marketing Strategy

                17.2.10.7.2. Product Strategy

                17.2.10.7.3. Channel Strategy

        17.2.11. Pro Lab Diagnostics Inc.

            17.2.11.1. Overview

            17.2.11.2. Product Portfolio

            17.2.11.3. Analyst Commentary 

            17.2.11.4. Key Financials

            17.2.11.5. Recent Developments

            17.2.11.6. Sales Footprint

            17.2.11.7. Strategy Overview

                17.2.11.7.1. Marketing Strategy

                17.2.11.7.2. Product Strategy

                17.2.11.7.3. Channel Strategy

        17.2.12. Novacyt Group

            17.2.12.1. Overview

            17.2.12.2. Product Portfolio

            17.2.12.3. Analyst Commentary 

            17.2.12.4. Key Financials

            17.2.12.5. Recent Developments

            17.2.12.6. Sales Footprint

            17.2.12.7. Strategy Overview

                17.2.12.7.1. Marketing Strategy

                17.2.12.7.2. Product Strategy

                17.2.12.7.3. Channel Strategy

        17.2.13. Bio-rad Laboratories

            17.2.13.1. Overview

            17.2.13.2. Product Portfolio

            17.2.13.3. Analyst Commentary 

            17.2.13.4. Key Financials

            17.2.13.5. Recent Developments

            17.2.13.6. Sales Footprint

            17.2.13.7. Strategy Overview

                17.2.13.7.1. Marketing Strategy

                17.2.13.7.2. Product Strategy

                17.2.13.7.3. Channel Strategy

        17.2.14. ASURAGEN, INC.

            17.2.14.1. Overview

            17.2.14.2. Product Portfolio

            17.2.14.3. Analyst Commentary 

            17.2.14.4. Key Financials

            17.2.14.5. Recent Developments

            17.2.14.6. Sales Footprint

            17.2.14.7. Strategy Overview

                17.2.14.7.1. Marketing Strategy

                17.2.14.7.2. Product Strategy

                17.2.14.7.3. Channel Strategy

        17.2.15. CTK Biotech, Inc.

            17.2.15.1. Overview

            17.2.15.2. Product Portfolio

            17.2.15.3. Analyst Commentary 

            17.2.15.4. Key Financials

            17.2.15.5. Recent Developments

            17.2.15.6. Sales Footprint

            17.2.15.7. Strategy Overview

                17.2.15.7.1. Marketing Strategy

                17.2.15.7.2. Product Strategy

                17.2.15.7.3. Channel Strategy

18. Assumptions and Acronyms Used

19. Research Methodology

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Hematology Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type

Table 02: Hematology Diagnostics Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type

Table 03: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Modality

Table 04: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 05: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 06:  U.S Hematology Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type

Table 07: U.S Hematology Diagnostics Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type

Table 08: U.S Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Modality

Table 09: U.S Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 10:  Canada Hematology Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type

Table 11: Canada Hematology Diagnostics Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type

Table 12: Canada Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Modality

Table 13: Canada Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 14: Latin America Hematology Diagnostics Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type

Table 15: Latin America Hematology Diagnostics Market Volume (Units) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type

Table 16: Latin America Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Modality

Table 17: Latin America Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 18: Latin America Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Hematology Diagnostics Market Volume (Units) Analysis, 2016-2020

Figure 02: Hematology Diagnostics Market Volume (Units) & Y-o-Y Growth (%), 2021–2031

Figure 03:  and Regional Average Pricing Analysis Benchmark - USD (per kit) By Kit Type (2020)

Figure 04: Hematology Diagnostics Market Value (US$ Mn) Analysis, 2016-2020

Figure 05: Hematology Diagnostics Market Value (US$ Mn) & Y-o-Y Growth (%), 2021–2031

Figure 06: Hematology Diagnostics Market Incremental $ Opportunity, 2021-2031

Figure 07: Hematology Diagnostics Market Analysis by Kit Type –2021 & 2031

Figure 08: Hematology Diagnostics Market Y-o-Y Growth Projections by Kit Type, 2021 – 2031

Figure 09: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type

Figure 10: Hematology Diagnostics Market Analysis by Modality –2021 & 2031

Figure 11: Hematology Diagnostics Market Y-o-Y Growth Projections by Modality, 2021 – 2031

Figure 12: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Modality

Figure 13: Hematology Diagnostics Market Analysis by Distribution Channel –2021 & 2031

Figure 14: Hematology Diagnostics Market Y-o-Y Growth Projections by Distribution Channel, 2021 – 2031

Figure 15: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Figure 16: Hematology Diagnostics Market Analysis by Region –2021 & 2031

Figure 17: Hematology Diagnostics Market Y-o-Y Growth Projections by Region, 2021 – 2031

Figure 18: Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Figure 19: Hematology Diagnostics Market Split By Product Type (2021E)

Figure 20: Hematology Diagnostics Market Split By Modality (2021E)

Figure 21: Hematology Diagnostics Market Split By Distribution Channel (2021E)

Figure 22: U.S Hematology Diagnostics Market Value (US$ Mn), Historical, 2016-2020

Figure 23: U.S Hematology Diagnostics Market Value (US$ Mn), Forecast, 2021-2031

Figure 24: U.S Hematology Diagnostics Market Attractiveness Analysis by Modality, 2021-2031

Figure 25: U.S Hematology Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021-2031

Figure 26: U.S Hematology Diagnostics Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Kit Type

Figure 27: Hematology Diagnostics Market Split By Product Type (2021E)

Figure 28: Hematology Diagnostics Market Split By Modality (2021E)

Figure 29: Hematology Diagnostics Market Split By Distribution Channel (2021E)

Figure 30: Canada Hematology Diagnostics Market Value (US$ Mn), Historical, 2016-2020

Figure 31: Canada Hematology Diagnostics Market Value (US$ Mn), Forecast, 2021-2031

Figure 32: Canada Hematology Diagnostics Market Attractiveness Analysis 2021-2031, by Modality, 

Figure 33: Canada Hematology Diagnostics Market Attractiveness Analysis, 2021-2031 by Distribution Channel

Figure 34: Canada Hematology Diagnostics Market Attractiveness Analysis, 2021 - 2031, By Kit Type

Figure 35: Latin America Hematology Diagnostics Market Split By Product Type (2021E)

Figure 36: Latin America Hematology Diagnostics Market Split By Modality (2021E)

Figure 37: Latin America Hematology Diagnostics Market Split By Distribution Channel (2021E)

Figure 38: Latin America Hematology Diagnostics Market Value (US$ Mn), Historical, Forecast 2016-2020

Figure 39: Latin America Hematology Diagnostics Market Value (US$ Mn), Forecast, 2021-2031

Figure 40: Latin America Hematology Diagnostics Market Attractiveness Analysis by Modality, 2021-2031

Figure 41: Latin America Hematology Diagnostics Market Attractiveness Analysis by Distribution Channel, 2021-2031

Figure 42: Latin America Hematology Diagnostics Market Attractiveness Analysis, 2021 - 2031, By Kit Type

Figure 43: Latin America Hematology Diagnostics Market Attractiveness Analysis, 2021 - 2031, By Country

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Americas Hematology Diagnostics Market

Schedule a Call

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services